David J Li - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

ACS Chemical Biology|February 3, 2015

Visualizing cell proximity with genetically encoded bioluminescent reportersKrysten A Jones, David J Li, Elliot Hui, et al.

Integrative Biology : Quantitative Biosciences From Nano to Macro|December 22, 2016

Patterning of sharp cellular interfaces with a reconfigurable elastic substrateAllison Curtis, David J Li, Brian DeVeale, et al.

Annals of Biomedical Engineering|January 22, 2017

Compartmentalized Culture of Perivascular Stroma and Endothelial Cells in a Microfluidic Model of the Human EndometriumJuan S Gnecco, Virginia Pensabene, David J Li, et al.

Transplantation|June 9, 2023

Relative Lung Perfusion on Ventilation-Perfusion Scans After Double Lung TransplantDavid J Li, Jonathan Abele, Parveen Sunner, et al.

Pain|May 27, 2020

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safetyJohn D Markman, Robert B Bolash, Timothy E McAlindon, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

ACS Chemical Biology|February 3, 2015

Visualizing cell proximity with genetically encoded bioluminescent reportersKrysten A Jones, David J Li, Elliot Hui, et al.

Integrative Biology : Quantitative Biosciences From Nano to Macro|December 22, 2016

Patterning of sharp cellular interfaces with a reconfigurable elastic substrateAllison Curtis, David J Li, Brian DeVeale, et al.

Annals of Biomedical Engineering|January 22, 2017

Compartmentalized Culture of Perivascular Stroma and Endothelial Cells in a Microfluidic Model of the Human EndometriumJuan S Gnecco, Virginia Pensabene, David J Li, et al.

Transplantation|June 9, 2023

Relative Lung Perfusion on Ventilation-Perfusion Scans After Double Lung TransplantDavid J Li, Jonathan Abele, Parveen Sunner, et al.

Pain|May 27, 2020

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safetyJohn D Markman, Robert B Bolash, Timothy E McAlindon, et al.

Pageof 1